California Condor Recovery Program Implements Vaccines in Pre-Release Condors Based on Early Trial Results
LOS ANGELES and SAN DIEGO, and PORTLAND, Ore., Oct. 16, 2023 /PRNewswire/ -- The U.S. Fish & Wildlife Service (Service) is sharing early results from the historic vaccine trial for highly pathogenic avian influenza (HPAI) in California condors (Gymnogyps californianus). As reported by the Service's Incident Command leading the effort, results from the first test group showed that 60% of the condors produced measurable antibodies that are expected to provide partial protection against mortality from HPAI if the birds are exposed.
- Fish & Wildlife Service (Service) is sharing early results from the historic vaccine trial for highly pathogenic avian influenza (HPAI) in California condors (Gymnogyps californianus).
- Zoo), San Diego Zoo Wildlife Alliance (SDZWA), and the Oregon Zoo as longtime California Condor Recovery Program partners, and with a new recovery partner, the Carolina Raptor Center.
- None of this important work would be possible without the collaboration from all our partners," said Ashleigh Blackford, California Condor Recovery Program Coordinator for the Service.
- The California Condor Recovery Program has long been an example of how partnerships can help promote recovery of endangered species.